Medaphor Group (MED)

Sector:

Health Care

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

8.75p
   
  • Change Today:
      0.25p
  • 52 Week High: 19.00
  • 52 Week Low: 8.25
  • Currency: UK Pounds
  • Shares Issued: 90.70m
  • Volume: 14,189
  • Market Cap: 7.94m
  • RiskGrade: 226
  • Beta: 0.00

Medaphor Group Overview

Medaphor Group is in the health care sector and is currently trading at 8.75p per share. In the last year Medaphor Group's share price has ranged from 8.25p to 19.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -132.5% -72.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.9 1.5
Pr/Book 1.1  
Latest F'cast
Revenue 27.1% 30.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Medaphor Group Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Dec-14 1.80 (1.51) (3,877.03)p n/a n/a n/a n/a 0.0%
31-Dec-14 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-15 2.21 (1.67) (8.10)p n/a n/a n/a n/a 0.0%
31-Dec-16 3.29 (2.49) (8.83)p n/a n/a n/a n/a 0.0%
31-Dec-17 4.18 (5.55) (11.70)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Medaphor Group Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 5.43 (3.94) (4.20)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Medaphor Group Company Announcements

Result of AGM 17-May-2018 10:54 RNS
AGM Statement 17-May-2018 07:00 RNS
Notice of AGM 24-Apr-2018 07:00 RNS

Latest Medaphor Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Medaphor Group Market Data

Currency UK Pounds
Share Price 8.75p
Change Today 0.25p
% Change 2.94 %
52 Week High 19.00
52 Week Low 8.25
Volume 14,189
Shares Issued 90.70m
Market Cap 7.94m
Beta 0.00
RiskGrade 226

Medaphor Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.07% above the market average28.07% above the market average28.07% above the market average28.07% above the market average28.07% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average
Price Trend
91.88% below the market average91.88% below the market average91.88% below the market average91.88% below the market average91.88% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average
Income Not Available
Growth
31.76% above the market average31.76% above the market average31.76% above the market average31.76% above the market average31.76% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Medaphor Group Dividends

No dividends found

Trades for 18-May-2018

Time Volume / Share Price
10:07 7,539 @ 8.70p
08:00 6,650 @ 8.71p

Medaphor Group Key Personnel

CEO Stuart Gall
Finance Director Wilson Jennings
COO Ian Whittaker

Top of Page